AUPS251402A0 - Kinase inhibitors - Google Patents

Kinase inhibitors

Info

Publication number
AUPS251402A0
AUPS251402A0 AUPS2514A AUPS251402A AUPS251402A0 AU PS251402 A0 AUPS251402 A0 AU PS251402A0 AU PS2514 A AUPS2514 A AU PS2514A AU PS251402 A AUPS251402 A AU PS251402A AU PS251402 A0 AUPS251402 A0 AU PS251402A0
Authority
AU
Australia
Prior art keywords
kinase inhibitors
kinase
inhibitors
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AUPS2514A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Cytopia Pty Ltd
Original Assignee
Cytopia Pty Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cytopia Pty Ltd filed Critical Cytopia Pty Ltd
Priority to AUPS2514A priority Critical patent/AUPS251402A0/en
Publication of AUPS251402A0 publication Critical patent/AUPS251402A0/en
Priority to JP2004507468A priority patent/JP4772325B2/ja
Priority to PCT/AU2003/000628 priority patent/WO2003099811A1/en
Priority to AU2003229370A priority patent/AU2003229370B2/en
Priority to GB0318343A priority patent/GB2398781B/en
Priority to EP03722065A priority patent/EP1511742B1/en
Priority to DE60331187T priority patent/DE60331187D1/de
Priority to AT03722065T priority patent/ATE457025T1/de
Priority to CA2486187A priority patent/CA2486187C/en
Priority to IL16526203A priority patent/IL165262A0/xx
Priority to CN038174529A priority patent/CN1671696B/zh
Priority to NZ537156A priority patent/NZ537156A/en
Priority to US10/472,156 priority patent/US7259179B2/en
Priority to IL165262A priority patent/IL165262A/en
Priority to ZA200409346A priority patent/ZA200409346B/en
Priority to US11/397,982 priority patent/US7511047B2/en
Priority to US11/397,973 priority patent/US7598272B2/en
Priority to US11/711,957 priority patent/US20070161635A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/4965—Non-condensed pyrazines
    • A61K31/497—Non-condensed pyrazines containing further heterocyclic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
AUPS2514A 2002-05-23 2002-05-23 Kinase inhibitors Abandoned AUPS251402A0 (en)

Priority Applications (18)

Application Number Priority Date Filing Date Title
AUPS2514A AUPS251402A0 (en) 2002-05-23 2002-05-23 Kinase inhibitors
US10/472,156 US7259179B2 (en) 2002-05-23 2003-05-23 Kinase inhibitors
CA2486187A CA2486187C (en) 2002-05-23 2003-05-23 Kinase inhibitors
CN038174529A CN1671696B (zh) 2002-05-23 2003-05-23 激酶抑制剂
AU2003229370A AU2003229370B2 (en) 2002-05-23 2003-05-23 Kinase inhibitors
GB0318343A GB2398781B (en) 2002-05-23 2003-05-23 Kinase inhibitors
EP03722065A EP1511742B1 (en) 2002-05-23 2003-05-23 Kinase inhibitors
DE60331187T DE60331187D1 (de) 2002-05-23 2003-05-23 Kinaseinhibitoren
AT03722065T ATE457025T1 (de) 2002-05-23 2003-05-23 Kinaseinhibitoren
JP2004507468A JP4772325B2 (ja) 2002-05-23 2003-05-23 キナーゼ阻害剤
IL16526203A IL165262A0 (en) 2002-05-23 2003-05-23 Kinase inhibitors
PCT/AU2003/000628 WO2003099811A1 (en) 2002-05-23 2003-05-23 Kinase inhibitors
NZ537156A NZ537156A (en) 2002-05-23 2003-05-23 Kinase inhibitors
IL165262A IL165262A (en) 2002-05-23 2004-11-16 Kinase inhibitors and pharmaceutical compositions containing them
ZA200409346A ZA200409346B (en) 2002-05-23 2004-11-19 Kinase inhibitors.
US11/397,982 US7511047B2 (en) 2002-05-23 2006-04-04 Kinase inhibitors
US11/397,973 US7598272B2 (en) 2002-05-23 2006-04-04 Kinase inhibitors
US11/711,957 US20070161635A1 (en) 2002-05-23 2007-02-27 Kinase inhibitors

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
AUPS2514A AUPS251402A0 (en) 2002-05-23 2002-05-23 Kinase inhibitors

Publications (1)

Publication Number Publication Date
AUPS251402A0 true AUPS251402A0 (en) 2002-06-13

Family

ID=3836078

Family Applications (1)

Application Number Title Priority Date Filing Date
AUPS2514A Abandoned AUPS251402A0 (en) 2002-05-23 2002-05-23 Kinase inhibitors

Country Status (3)

Country Link
JP (1) JP4772325B2 (https=)
AU (1) AUPS251402A0 (https=)
ZA (1) ZA200409346B (https=)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4769720B2 (ja) * 2003-08-21 2011-09-07 オーエスアイ・ファーマシューテイカルズ・エル・エル・シー Ｎ−置換ベンズイミダゾリルｃ−Ｋｉｔ阻害剤
NZ545694A (en) * 2003-12-03 2010-04-30 Ym Bioscience Australia Pty Lt Azole-based kinase inhibitors
US8513276B2 (en) * 2006-12-22 2013-08-20 Astex Therapeutics Limited Imidazo[1,2-a]pyridine compounds for use in treating cancer
GB0720038D0 (en) * 2007-10-12 2007-11-21 Astex Therapeutics Ltd New compounds
GB0720041D0 (en) * 2007-10-12 2007-11-21 Astex Therapeutics Ltd New Compounds
EP2338888A1 (en) * 2009-12-24 2011-06-29 Almirall, S.A. Imidazopyridine derivatives as JAK inhibitors

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1169038B9 (en) * 1999-04-15 2013-07-10 Bristol-Myers Squibb Company Cyclic protein tyrosine kinase inhibitors
HK1054393B (en) * 2000-09-20 2009-08-28 Ortho-Mcneil Pharmaceutical, Inc. Pyrazine derivatives as modulators of tyrosine kinases

Also Published As

Publication number Publication date
JP2005535597A (ja) 2005-11-24
JP4772325B2 (ja) 2011-09-14
ZA200409346B (en) 2006-02-22

Similar Documents

Publication Publication Date Title
AU2003249442A1 (en) Kinase inhibitors
AU2003222055A1 (en) Kinase inhibitors
AU2003271566A1 (en) Pyrrolopyrazines as kinase inhibitors
AU2003265349A1 (en) Pyrrolotriazine kinase inhibitors
AU2003299651A1 (en) Tyrosine kinase inhibitors
AU2003202263A1 (en) Roh-kinase inhibitors
AU2003259749A1 (en) 3-pyrrolyl-pyridopyrazoles and 3-pyrrolyl-indazoles as novel kinase inhibitors
SI1569907T1 (sl) Na nikotinamidu osnovani kinazni inhibitorji
AU2003259153A1 (en) Substituted triazine kinase inhibitors
AU2003245555A1 (en) Sphingosine kinase inhibitors
IL165515A0 (en) Bisindolyl-maleimid derivatives as kinase inhibitors
AU2003282891A1 (en) Novel tyrosine kinases inhibitors
AU2003237446A1 (en) Pyrazole-derivatives as p38 kinase inhibitors
AU2003298942A1 (en) Tyrosine kinase inhibitors
EP1558609A4 (en) KINASE INHIBITORS
AU2003284399A1 (en) Plk inhibitors
AU2003275282A1 (en) Novel tyrosine kinase inhibitors
AU2003254051A1 (en) Pyrazolopyrimidines as kinase inhibitors
AU2003261204A1 (en) Pyrazolopyrimidines as kinase inhibitors
AU2002953255A0 (en) Protein kinase inhibitors
AU2003289386A1 (en) Jnk inhibitors
AU2003249683A1 (en) Nf-:b inhibitors
EP1569907A4 (en) NICOTINAMIDE-BASED KINASE HEMMER
AU2003220437A1 (en) Thiopyrimidine and isothiazolopyrimidine kinase inhibitors
AU2003302588A1 (en) Phosphodiesterase 10a inhibitors